Elaine Abrams is a Professor of Epidemiology and Pediatrics at Columbia University with over 35 years of experience in the prevention and treatment of HIV infection and associated infectious diseases in pregnant women, children, and their families. Dr. Abrams has chaired the WHO consolidated guidelines for the use of antiretroviral drugs since 2015 and is also co-chair of the WHO Pediatric Antiretroviral Working Group. Her research interests focus on maternal-child health, mother-to-child HIV transmission, the natural history of pediatric HIV, and optimizing therapy.
At the completion of this educational session, learners will:
- Recognize global progress in the prevention of new pediatric HIV infections.
- Identify optimal antiretroviral regimens for use during pregnancy and breastfeeding.
- Describe gaps along the cascade of care for the prevention of vertical HIV transmission.
- Describe the impact of the SARS-CoV2 pandemic on HIV services for pregnant women and infants.
This CME activity has approved for
AMA PRA Category 1 Credit™ for December 9, 2020 as a live activity. This activity will also be available as an enduring activity from December 10, 2020, through December 8, 2023.
The target audience is all physicians, NPs and PAs involved or interested in HIV education.
This online video and post-activity evaluation are one hour in length.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.
The Medical Society of the State of New York designates this enduring material for a maximum of 1.0
AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with extent of their participation in the activity.
Policies and standards of the Medical Society of the State of New York and the Accreditation Council for Continuing Medical Education require that speakers and planners for continuing medical education activities disclose any relevant financial relationships they may have with commercial interests whose products, devices, or services may be discussed in the content of a CME activity.
- Dr. James F. Braun, DO (Course Director) has no relevant financial relationships to disclose.
- Dr. William M. Valenti (Moderator) has no relevant financial relationships to disclose.
- Dr. Elaine J. Abrams (Presenter) has no relevant financial relationships to disclose. Dr. Abrams will support her presentation and clinical recommendations with the best available evidence from the medical literature and will submit her slides in advance for adequate peer review.
This PRN CME activity is funded in part by unrestricted educational grants from:
Gilead Sciences; Janssen Therapeutics, a division of Janssen Products, LP; Merck & Co.; and ViiV Healthcare
‘Click here to take the CME Evaluation and Post-Meeting Evaluation
Download Article PDF/Slides